The bill enacts R.S. 46:450.5.1, which focuses on addressing chronic and rare kidney diseases in Louisiana. It outlines the legislative intent to enhance awareness, prevention, and treatment of kidney diseases, which affect over thirty-five million Americans. The bill emphasizes the importance of early detection and intervention to mitigate the progression of kidney disease, which can lead to costly treatments like dialysis. It also highlights the need for the Louisiana Department of Health to conduct annual reviews of medications and treatments available under Medicaid for individuals diagnosed with these conditions.

Additionally, the Louisiana Department of Health is tasked with soliciting public input during these reviews, particularly from those knowledgeable about kidney diseases. The department is encouraged to form strategic partnerships to improve education and screening initiatives. Furthermore, the bill mandates the department to submit an annual report detailing the findings from these reviews and any recommendations to the legislature, ensuring transparency and ongoing evaluation of kidney disease management in the state.